LAB TESTING

People often use the words “cannabis” and “marijuana” interchangeably, but they don’t mean exactly the same thing. The word “cannabis” refers to all products derived from the plant Cannabis sativa. The cannabis plant contains about 540 chemical substances. The word “marijuana” refers to parts of or products from the plant Cannabis sativa that contain substantial amounts of tetrahydrocannabinol (THC). THC is the substance that’s primarily responsible for the effects of marijuana on a person’s mental state. Some cannabis plants contain very little THC. Under U.S. law, these plants are considered “industrial hemp” rather than marijuana.

Cannabinoids are a group of substances found in the cannabis plant.

The main cannabinoids are THC and cannabidiol (CBD).

Besides THC and CBD, more than 100 other cannabinoids have been identified.

The FDA has not approved the cannabis plant for any medical use. However, the FDA has approved several drugs that contain individual cannabinoids. Epidiolex, which contains a purified form of CBD derived from cannabis, was approved for the treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome, two rare and severe forms of epilepsy. Marinol and Syndros, which contain dronabinol (synthetic THC), and Cesamet, which contains nabilone (a synthetic substance similar to THC), are approved by the FDA. Dronabinol and nabilone are used to treat nausea and vomiting caused by cancer chemotherapy. Dronabinol is also used to treat loss of appetite and weight loss in people with HIV/AIDS.

The FDA has determined that products containing THC or CBD cannot be sold legally as dietary supplements. Foods to which THC or CBD has been added cannot be sold legally in interstate commerce. Whether they can be sold legally within a state depends on that state’s laws and regulations.

Drugs containing cannabinoids may be helpful in treating certain rare forms of epilepsy, nausea and vomiting associated with cancer chemotherapy, and loss of appetite and weight loss associated with HIV/AIDS. In addition, some evidence suggests modest benefits of cannabis or cannabinoids for chronic pain and multiple sclerosis symptoms. Cannabis isn’t helpful for glaucoma. Research on cannabis or cannabinoids for other conditions is in its early stages. The following sections summarize the research on cannabis or cannabinoids for specific health conditions.

Several concerns have been raised about the safety of cannabis and cannabinoids: The use of cannabis has been linked to an increased risk of motor vehicle crashes. Smoking cannabis during pregnancy has been linked to lower birth weight. Some people who use cannabis develop cannabis use disorder, which has symptoms such as craving, withdrawal, lack of control, and negative effects on personal and professional responsibilities. Adolescents using cannabis are four to seven times more likely than adults to develop cannabis use disorder. Cannabis use is associated with an increased risk of injury among older adults. The use of cannabis, especially frequent use, has been linked to a higher risk of developing schizophrenia or other psychoses (severe mental illnesses) in people who are predisposed to these illnesses. Marijuana may cause orthostatic hypotension (head rush or dizziness on standing up), possibly raising danger from fainting and falls. The FDA has warned the public not to use vaping products that contain THC. Products of this type have been implicated in many of the reported cases of serious lung injuries linked to vaping. There have been many reports of unintentional consumption of cannabis or its products by children, leading to illnesses severe enough to require emergency room treatment or admission to a hospital. Among a group of people who became ill after accidental exposure to candies containing THC, the children generally had more severe symptoms than the adults and needed to stay in the hospital longer. Some long-term users of high doses of cannabis have developed a condition involving recurrent severe vomiting. There have been reports of contamination of cannabis/cannabinoid products with microorganisms, pesticides, or other substances. Some cannabis/cannabinoid products contain amounts of cannabinoids that differ substantially from what’s stated on their labels.

There’s evidence that CBD may be harmful to some people. Before the FDA approved Epidiolex (a purified CBD product) as a drug, studies were done to evaluate its effectiveness and safety. Some participants in these studies had side effects (mostly diarrhea or sleepiness), and some developed abnormalities on tests of liver function. In some instances, study participants had to discontinue Epidiolex because of liver problems. Epidiolex also interacted with some of the other drugs these people were taking. Problems like these can be managed in patients taking Epidiolex because they’re using CBD under medical supervision. People who use CBD on their own don’t have this kind of protection. They may not even know how much CBD they’re taking. A 2017 analysis of 84 CBD products sold online found that 26 percent contained substantially less CBD than the label indicated, and 43 percent contained substantially more.

CBD (or Cannabidiol) is one of over 100 active compounds found in the cannabis plant and is known for its interaction with the Endocannabinoid System when ingested.

The Endocannabinoid System (ECS) helps the body maintain homeostasis, or balance, by communicating with and supporting other biological systems in the body.

The ECS regulates and balances a variety of responses in the body: stress, appetite, sensation, mood, energy, metabolism, skin function and more.

The Skin contains cannabinoid receptors, cannabinoid synthesis and degradation enzymes that certain studies suggest can affect functions in various parts of the skin, including: Epidermis – skin barrier/protection, health, and appearance; Sensory Nerves -sensation; Immune Cells –immune response; Sebaceous Glands – Sebum production; Hair Follicles – Hair loss/ growth/ maintenance; Sweat Glands – sweat production.

No. CBD is a non-intoxicating cannabinoid.

Drug tests vary as to what compounds are being analyzed, so we are unable to make any claims or guarantees regarding use of our products and drug tests.

No, Ameyalli Hemp products are not tested on animals and are cruelty free.

Finished product not tested on animals.

Check your product packaging for the expiration date.

All products should be stored at room temperature (not higher than 75 degrees Fahrenheit).

We strive to make a range of products available to people with dietary restrictions. Please check the product pages for product-specific information on allergens.

Our products are intended for adults 21 and over.

Ameyalli products undergo extensive third-party testing throughout the manufacturing process to ensure that each product is tested for heavy metals, microbiological contaminants, residual solvents and pesticides. Ameyalli products feature whole plant formulas derived from carefully selected hemp cultivated in the USA. Our finished goods are tested and traceable on our site through a lab batch code.

You can view finished goods test results on our website through our COA page. Click the link or scan the code for the product (found imprinted on the bottle/jar or on the label) this will take you directly to our site where you can “Download the Report” for a PDF version of the results through our third party test provider.


We ship our products to many states in the USA. We do not ship internationally at this time.

Email us at info@ameyallihemp.com

Please email us at info@ameyallihemp.com as soon as possible if you want to change or cancel your order or change the shipping method. We process orders quickly but will do our best to accommodate your request.

Free Standard Shipping orders typically take 1-10 business days depending on your location. Standard Shipping orders are processed within 48-72 hours of receipt, Monday through Friday. Orders received after 2 pm on Friday and on weekends will be processed the following Monday. Please see Shipping Policy for details.

Yes, we offer 1-day and 2-day express shipping. Please see Shipping Policy for details.

Ameyalli Hemp offers Free Standard Shipping on all of our products.

 Free Standard Shipping is offered via USPS, and/or UPS and takes 1-10 business days, depending on location and product mix.
 
Please see Shipping Policy for details.
 Express shipping options are available within (2 business day and overnight). Express shipping charges are based on your location and will be calculated and presented during the checkout process.

We have found that often USPS does not scan packages at the point of origin, so the online tracking shows not shipped even if the package was shipped. If you have a concern about your order, email us at info@ameyallihemp.com and we will confirm date of shipment.

Please consult your physician before using our products if you are pregnant.

Please consult your physician before using our products if you are pregnant or taking prescription medicine.

Please consult your physician before using our products if you have a medical condition